Telos Corporation, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations
September 23, 2024 08:28 ET
|
Telos Corporation
ASHBURN, Va., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), an authorized enrollment provider, continues to expand locations to enroll consumers in the TSA PreCheck® program by...
BIO-key Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control
September 23, 2024 08:28 ET
|
BIO-key International, Inc.
BIO-key, International (BKYI) Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control.
SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment
September 23, 2024 08:17 ET
|
SciSparc Ltd
FDA confirms that SciSparc’s study may proceed following the application submission a month ago TEL AVIV, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or...
Matthews International Announces Proposed Private Offering of Senior Notes
September 23, 2024 08:15 ET
|
Matthews International Corporation
PITTSBURGH, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (NASDAQ GSM: MATW) (the “Company”) today announced a proposed private offering of senior secured second lien notes...
Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza
September 23, 2024 08:00 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC)...
Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress
September 23, 2024 08:00 ET
|
Intra-Cellular Therapies Inc.
Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) Poster...
Monster Digital Adds Significant Digital Production Capacity with the Adoption of 10 Additional Kornit Apollo Systems During 2025
September 23, 2024 08:00 ET
|
Kornit Digital Ltd
On demand manufacturer serves the world’s largest global brands, retailers and e-commerce platformsOperates three locations, nearshore and onshore, running 24/7, promoting new product delivery and...
Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi
September 23, 2024 08:00 ET
|
Ventyx Biosciences, Inc.
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a...
Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference
September 23, 2024 08:00 ET
|
Solid Biosciences Inc.
CHARLESTOWN, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for...
Xunlei Announces Appointment of Two New Directors
September 23, 2024 08:00 ET
|
Xunlei Limited
SHENZHEN, China, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading technology company providing distributed cloud services in China, today...